Latest Alkaloids Stories
NEW YORK, July 14 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc.
BOTHELL, WA, and VANCOUVER, June 21 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.
PARIS, June 17 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the U.S.
The June edition of the Journal of Thoracic Oncology features a study aimed at determining the optimal dose of the chemotherapy drug nab-paclitaxel with carboplatin as a first-line therapy in patients with non-small cell lung cancer (NSCLC).
DESCRIBES PHASE 2 DEVELOPMENT PLANS FOR PX-866 SEATTLE, WA, June 7 /PRNewswire-FirstCall/ - Oncothyreon Inc.
Results Presented at ASCO 2010 Annual Meeting Confirm Acceptable Safety Profile and Evidence of Biological Activity Including Declines in Circulating Tumor Cells and Reductions in Tumor Markers BOTHELL, WA, and VANCOUVER, June 7 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc.
CHICAGO, June 7 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
SEATTLE, May 24 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., May 10 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc.
PHILADELPHIA, May 6 /PRNewswire/ -- URL Pharma, Inc., today announced that the U.S. Food and Drug Administration (FDA) has issued new label information affecting all approved protease inhibitors for treatment of HIV when co-administered with ColcrysÂ® (colchicine, USP).
- The governor of a province or people.